Состав:
Страница осмотрена фармацевтом Коваленко Светланой Олеговной Последнее обновление 17.04.2022
Внимание! Информация на странице предназначена только для медицинских работников! Информация собрана в открытых источниках и может содержать значимые ошибки! Будьте внимательны и перепроверяйте всю информацию с этой страницы!
Топ 20 лекарств с такими-же компонентами:
For use Max Pidek Pharmaceuticals as monotherapy and in combination with clavulanic acid: an infectious-inflammatory diseases caused by susceptible microorganisms, including bronchitis, pneumonia, tonsillitis, pyelonephritis, urethritis, infections of the gastrointestinal tract, gynecological infections, infections of the skin and soft tissue, listeria, leptospirosis, gonorrhea.
For use Max Pidek Pharmaceuticals in combination with metronidazole: chronic gastritis in acute, peptic ulcer and duodenal ulcer in acute, associated with Helicobacter Pylori.
An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.Guaifenesin (Levolin PLUS) and hydrocodone is used to treat cough and reduce chest congestion caused by the common cold, flu, or allergies.
Relieving cough and throat and airway irritation due to colds, flu, or hay fever. It may also be used for other conditions as determined by your doctor.
Ambroxol (Levolin PLUS) is a cough suppressant and expectorant combination. The cough suppressant works in the brain to help decrease the cough reflex to reduce a dry cough. The expectorant works by loosening mucus and lung secretions in the chest and making coughs more productive.
Guaifenesin (Levolin PLUS) is used to reduce chest congestion caused by the common cold, flu, or chronic bronchitis.
Guaifenesin (Levolin PLUS) helps loosen congestion in your chest and throat, making it easier to cough out through your mouth.
There are many brands and forms of Guaifenesin (Levolin PLUS) available. Not all brands are listed on this leaflet.
Guaifenesin (Levolin PLUS) may also be used for purposes not listed in this medication guide.
Капсула с устойчивым высвобождением: Взрослые и дети> 12 лет 1 колпачок один раз в день после еды с большим количеством жидкости (достаточный запас жидкости поддерживает отхаркивающее действие амброксола (Levolin PLUS)).
Капсула Амброксол (Levolin PLUS) SR не подходит для детей до 12 лет.
Таблетка: Взрослые и дети> 12 лет 1 вкладка трижды в день в течение первых 2-3 дней, а затем 1 вкладка два раза в день или ½ вкладки трижды в день. Дети 6-12 лет : ½ вкладки 2-3 раза в день.
Сироп: Взрослые и дети> 12 лет 10 мл трижды в день в течение первых 2-3 дней, их 10 мл два раза в день или 5 мл трижды в день. Дети 6-12 лет : 5 мл 2-3 раза в день; 2-5 лет : 2,5 мл 3 раза в день; <2 года: 2,5 мл 2 раза в день.
DS Syrup : Взрослые и дети> 12 лет 5 мл трижды в день в течение 2-3 дней, затем 5 мл два раза в день в течение 2,5 мл трижды в день. Дети 6-12 лет : 2,5 мл 2-3 раза в день.
Младенческие капли: Дети 13-24 месяцев : 1,25 мл два раза в день; 7-12 месяцев : 1 мл два раза в день; ≤6 месяцев: 0,5 мл два раза в день.
ORGANIDIN® NR (Гуаифензин (Леволин ПЛЮС))
Таблетки - Взрослые и дети в возрасте от 12 лет и старше: от одной до 2 таблеток (от 200 до 400 мг) каждые четыре часа, не более 2400 мг (12 таблеток) в течение 24 часов.
ПАЦИЕНТЫ ДОЛЖНЫ СОВЕТСТВОВАТЬ, ЧТОБЫ СОХРАНИТЬ ЭТИ И ВСЕ НАРКОТИКИ ИЗ ДОСТУПА ДЕТЕЙ И УВИДЕТЬ ПРОФЕССИОНАЛЬНУЮ ПОМОЩЬ ИЛИ СВЯЗАТЬСЯ С ЦЕНТРОМ КОНТРОЛЯ ЯД НЕМЕДЛЕННО В СЛУЧАЕ АВАРИЙНОЙ ОБЕСПЕЧЕНИЯ .
Как поставляется
ORGANIDIN® NR (Гуаифензин (Леволин ПЛЮС))
Таблетки - Каждая таблетка розового цвета с оценкой содержит 200 мг гуафенезина (Levolin PLUS) USP - доступно в бутылках по 100 (NDC 0037-4312-01)
Хранение
Хранить при контролируемой комнатной температуре 20 ° -25 ° C (68 ° -77 ° F). Защитите таблетки от влаги. Держите бутылку плотно закрытой.
Чтобы сообщить о ПОДВЕСКИХ РЕАКЦИЯХ ПОКРЫТИЯ, свяжитесь с Meda Pharmaceuticals Inc. по телефону 1-800-526-3840 или FDA по телефону 1-800-FDA-1088 или www.fda.gov/medwatch.
Meda Pharmaceuticals Inc. Сомерсет, Нью-Джерси 08873-4120. Rev. 11/09
Смотрите также:
Какую самую важную информацию я должен знать об Амброксоле (Леволин ПЛЮС)?
Повышенная чувствительность к гидрохлориду амброксола (леволин ПЛЮС) или к любым другим вспомогательным веществам амброксола (леволин ПЛЮС).
В случае редких наследственных состояний, которые могут быть несовместимы с эксципиентом амброксола (леволин ПЛЮС), использование амброксола (леволин ПЛЮС) противопоказано.
Use Ambroxol (Levolin PLUS) as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- Take Ambroxol (Levolin PLUS) by mouth with or without food.
- Drink plenty of water while taking Ambroxol (Levolin PLUS).
- If you miss a dose of Ambroxol (Levolin PLUS), take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.
Ask your health care provider any questions you may have about how to use Ambroxol (Levolin PLUS).
Use Guaifenesin (Levolin PLUS) sustained-release tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- Take Guaifenesin (Levolin PLUS) sustained-release tablets by mouth with or without food.
- Drinking extra fluids while you are taking Guaifenesin (Levolin PLUS) sustained-release tablets is recommended. Check with your doctor for instructions.
- Swallow Guaifenesin (Levolin PLUS) sustained-release tablets whole. Do not break, crush, or chew before swallowing.
- If you miss a dose of Guaifenesin (Levolin PLUS) sustained-release tablets and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose. Go back to your regular dosing schedule. Do not take 2 doses at once.
Ask your health care provider any questions you may have about how to use Guaifenesin (Levolin PLUS) sustained-release tablets.
There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.Ambroxol (Levolin PLUS) is used to treat certain diseases of the respiratory tract and to relieve cough associated with thickened mucous.
There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.Guaifenesin (Levolin PLUS) is used to treat coughs and congestion caused by the common cold, bronchitis, and other breathing illnesses. This product is usually not used for ongoing cough from smoking or long-term breathing problems (such as chronic bronchitis, emphysema) unless directed by your doctor. Guaifenesin (Levolin PLUS) is an expectorant. It works by thinning and loosening mucus in the airways, clearing congestion, and making breathing easier.
If you are self-treating with this medication, it is important to read the package instructions carefully before you start using this product to be sure it is right for you.
Cough-and-cold products have not been shown to be safe or effective in children younger than 6 years. Therefore, do not use this product to treat cold symptoms in children younger than 6 years unless specifically directed by the doctor. Some products (such as long-acting tablets/capsules) are not recommended for use in children younger than 12 years. Ask your doctor or pharmacist for more details about using your product safely.
These products do not cure or shorten the length of the common cold. To decrease the risk for side effects, carefully follow all dosage directions. Do not give other cough-and-cold medication that might contain the same or similar ingredients. Ask the doctor or pharmacist about other ways to relieve cough and cold symptoms (such as drinking enough fluids, using a humidifier or saline nose drops/spray).
How to use 2/G
Take this medication by mouth with or without food, as directed by your doctor, usually every 4 hours. If you are self-treating, follow all directions on the product package. If you are uncertain about any of the information, ask your doctor or pharmacist.
Guaifenesin (Levolin PLUS) may have a bitter taste. Do not split the tablets unless they have a score line and your doctor or pharmacist tells you to do so. Swallow the whole or split tablet without crushing or chewing.
If you are using the liquid form of this medication, carefully measure the dose using a special measuring device/spoon. Do not use a household spoon because you may not get the correct dose.
For powder packets, empty the entire contents of the packet onto the tongue and swallow. To prevent a bitter taste, do not chew.
Dosage is based on your age, medical condition, and response to treatment. Do not take more than 6 doses in a day. Do not increase your dose or take this drug more often than directed.
Drink plenty of fluids while taking this medication. Fluids will help to break up mucus and clear congestion.
Tell your doctor if your cough is accompanied by fever, severe sore throat, rash, persistent headache, or if it persists, returns, or worsens after 7 days. These may be signs of a serious medical problem. Seek immediate medical attention if you think you may have a serious medical problem.
See also:
What other drugs will affect Ambroxol (Levolin PLUS)?
Amoxicillin may decrease the effectiveness of contraceptives for oral administration.
With the simultaneous use of Max Pidek Pharmaceuticals with bactericidal antibiotics (including aminoglycosides, cephalosporins, cycloserine, vancomycin, rifampicin) appears synergies; with bacteriostatic antibiotic (including macrolides, chloramphenicol, lincosamides, tetracyclines, sulphonamide) - antagonism.
Amoxicillin increases the effects of indirect anticoagulants inhibiting intestinal microflora, reduces the synthesis of vitamin K and prothrombin index.
Amoxicillin reduces the effect of drugs, in the process of metabolism that produce PABA.
Probenecid, diuretics, allopurinol, phenylbutazone, NSAIDs decrease the tubular secretion of amoxicillin, which can be accompanied by an increase in its concentration in blood plasma.
Antacids, glucosamine, laxatives, aminoglycosides, slow down and reduce, and ascorbic acid increases the absorption of amoxicillin.
With the combined use of amoxicillin and clavulanic acid pharmacokinetics of both components unchanged.
See also:
What other drugs will affect Guaifenesin (Levolin PLUS)?
In vitro results suggest that methadone undergoes hepatic N-demethylation by cytochrome P450 enzymes, principally CYP3A4, CYP2B6, CYP2C19 and to a lesser extent by CYP2C9 and CYP2D6. Coadministration of methadone with CYP inducers of these enzymes may result in a more rapid metabolism and potential for decreased effects of methadone, whereas administration with CYP inhibitors may reduce metabolism and potentiate methadones effects. Although antiretroviral drugs such as efavirenz, nelfinavir, nevirapine, ritonavir, lopinavir+ritonavir combination are known to inhibit CYPs, they are shown to reduce the plasma levels of methadone, possibly due to their CYP induction activity. Therefore, drugs administered concomitantly with methadone should be evaluated for interaction potential; clinicians are advised to evaluate individual response to drug therapy.
Opioid Antagonists, Mixed Agonist/Antagonists, and Partial Agonists
As with other mu-agonists, patients maintained on methadone may experience withdrawal symptoms when given opioid antagonists, mixed agonist/antagonists, and partial agonists. Examples of such agents are naloxone, naltrexone, pentazocine, nalbuphine, butorphanol, and buprenorphine.
Anti-retroviral Agents
Abacavir, amprenavir, efavirenz, nelfinavir, nevirapine, ritonavir, lopinavir+ritonavir combination - Coadministration of these anti-retroviral agents resulted in increased clearance or decreased plasma levels of methadone. Guaifenesin (Levolin PLUS)-maintained patients beginning treatment with these antiretroviral drugs should be monitored for evidence of withdrawal effects and methadone dose should be adjusted accordingly.
Didanosine and Stavudine - Experimental evidence demonstrated that methadone decreased the AUC and peak levels for didanosine and stavudine, with a more significant decrease for didanosine. Guaifenesin (Levolin PLUS) disposition was not substantially altered.
Zidovudine - Experimental evidence demonstrated that methadone increased the area under the concentration-time curve (AUC) of zidovudine which could result in toxic effects.
Cytochrome P450 Inducers
Guaifenesin (Levolin PLUS)-maintained patients beginning treatment with CYP3A4 inducers should be monitored for evidence of withdrawal effects and methadone dose should be adjusted accordingly. The following drug interactions were reported following coadministration of methadone with inducers of cytochrome P450 enzymes:
Rifampin - In patients well-stabilized on methadone, concomitant administration of rifampin resulted in a marked reduction in serum methadone levels and a concurrent appearance of withdrawal symptoms.
Phenytoin - In a pharmacokinetic study with patients on methadone maintenance therapy, phenytoin administration (250 mg b.i.d. initially for 1 day followed by 300 mg QD for 3 to 4 days) resulted in an approximately 50% reduction in methadone exposure and withdrawal symptoms occurred concurrently. Upon discontinuation of phenytoin, the incidence of withdrawal symptoms decreased and methadone exposure increased to a level comparable to that prior to phenytoin administration.
St. Johns Wort, Phenobarbital, Carbamazepin/strong>Administration of methadone along with other CYP3A4 inducers may result in withdrawal symptoms.
Cytochrome P450 Inhibitors
Since the metabolism of methadone is mediated primarily by CYP3A4 isozyme, coadministration of drugs that inhibit CYP3A4 activity may cause decreased clearance of methadone. The expected clinical results would be increased or prolonged opioid effects. Thus, methadone-treated patients coadministered strong inhibitors of CYP3A4, such as azole antifungal agents (e.g., ketoconazole) and macrolide antibiotics (e.g., erythromycin), with methadone should be carefully monitored and dosage adjustment should be undertaken if warranted. Some selective serotonin reuptake inhibitors (SSRIs) (e.g., sertraline, fluvoxamine) may increase methadone plasma levels upon coadministration with methadone and result in increased opiate effects and/or toxicity.
Voriconazole - Repeat dose administration of oral voriconazole (400mg Q12h for 1 day, then 200mg Q12h for 4 days) increased the Cmax and AUC of (R)-methadone by 31% and 47%, respectively, in subjects receiving a methadone maintenance dose (30 to 100 mg QD). The Cmax and AUC of (S)-methadone increased by 65% and 103%, respectively. Increased plasma concentrations of methadone have been associated with toxicity including QT prolongation. Frequent monitoring for adverse events and toxicity related to methadone is recommended during coadministration. Dose reduction of methadone may be needed.
Others
Monoamine Oxidase (MAO) Inhibitors - Therapeutic doses of meperidine have precipitated severe reactions in patients concurrently receiving monoamine oxidase inhibitors or those who have received such agents within 14 days. Similar reactions thus far have not been reported with methadone. However, if the use of methadone is necessary in such patients, a sensitivity test should be performed in which repeated small, incremental doses of methadone are administered over the course of several hours while the patients condition and vital signs are under careful observation.
Desipramine - Blood levels of desipramine have increased with concurrent methadone administration.
Potentially Arrhythmogenic Agents
Extreme caution is necessary when any drug known to have the potential to prolong the QT interval is prescribed in conjunction with methadone. Pharmacodynamic interactions may occur with concomitant use of methadone and potentially arrhythmogenic agents such as class I and III antiarrhythmics, some neuroleptics and tricyclic antidepressants, and calcium channel blockers.
Caution should also be exercised when prescribing methadone concomitantly with drugs capable of inducing electrolyte disturbances (hypomagnesemia, hypokalemia) that may prolong the QT interval. These drugs include diuretics, laxatives, and, in rare cases, mineralocorticoid hormones.
Interactions with Alcohol and Drugs of Abuse
Guaifenesin (Levolin PLUS) may be expected to have additive effects when used in conjunction with alcohol, other opioids or CNS depressants, or with illicit drugs that cause central nervous system depression. Deaths have been reported when methadone has been abused in conjunction with benzodiazepines.
Anxiety - Since methadone as used by tolerant patients at a constant maintenance dosage does not act as a tranquilizer, patients who are maintained on this drug will react to life problems and stresses with the same symptoms of anxiety as do other individuals. The physician should not confuse such symptoms with those of narcotic abstinence and should not attempt to treat anxiety by increasing the dose of methadone. The action of methadone in maintenance treatment is limited to the control of narcotic withdrawal symptoms and is ineffective for relief of general anxiety.
Acute Pain - Maintenance patients on a stable dose of methadone who experience physical trauma, postoperative pain or other acute pain cannot be expected to derive analgesia from their existing dose of methadone. Such patients should be administered analgesics, including opioids, in doses that would otherwise be indicated for non-methadone-treated patients with similar painful conditions. Due to the opioid tolerance induced by methadone, when opioids are required for management of acute pain in methadone patients, somewhat higher and/or more frequent doses will often be required than would be the case for non-tolerant patients.
Risk of Relapse in Patients on Guaifenesin (Levolin PLUS) Maintenance Treatment of Opioid Addiction
Abrupt opioid discontinuation can lead to development of opioid withdrawal symptoms. Presentation of these symptoms have been associated with an increased risk of susceptible patients to relapse to illicit drug use and should be considered when assessing the risks and benefit of methadone use.
Tolerance and Physical Dependence
Tolerance is the need for increasing doses of opioids to maintain a defined effect such as analgesia (in the absence of disease progression or other external factors). Physical dependence is manifested by withdrawal symptoms after abrupt discontinuation of a drug or upon administration of an antagonist. Physical dependence and/or tolerance are not unusual during chronic opioid therapy.
If methadone is abruptly discontinued in a physically dependent patient, an abstinence syndrome may occur. The opioid abstinence or withdrawal syndrome is characterized by some or all of the following: restlessness, lacrimation, rhinorrhea, yawning, perspiration, chills, myalgia, and mydriasis. Other symptoms also may develop, including irritability, anxiety, backache, joint pain, weakness, abdominal cramps, insomnia, nausea, anorexia, vomiting, diarrhea, or increased blood pressure, respiratory rate, or heart rate.
In general, chronically administered methadone should not be abruptly discontinued.
Special-Risk Patients
Guaifenesin (Levolin PLUS) should be given with caution and the initial dose reduced in certain patients, such as the elderly and debilitated and those with severe impairment of hepatic or renal function, hypothyroidism, Addisons disease, prostatic hypertrophy, or urethral stricture. The usual precautions appropriate to the use of parenteral opioids should be observed and the possibility of respiratory depression should always be kept in mind.
Guaifenesin (Levolin PLUS) side effects
See also:
What are the possible side effects of Guaifenesin (Levolin PLUS)?
Applies to Guaifenesin (Levolin PLUS): oral capsule, oral capsule extended release, oral elixir, oral liquid, oral packet, oral solution, oral syrup, oral tablet, oral tablet extended release
In addition to its needed effects, some unwanted effects may be caused by Guaifenesin (Levolin PLUS) (the active ingredient contained in Guaifenesin (Levolin PLUS)). In the event that any of these side effects do occur, they may require medical attention.
Minor Side Effects
Some of the side effects that can occur with Guaifenesin (Levolin PLUS) may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:
Less common or rare:
- Diarrhea
- dizziness
- headache
- hives
- nausea or vomiting
- skin rash
- stomach pain
Guaifenesin (Levolin PLUS) contraindications
See also:
What is the most important information I should know about Guaifenesin (Levolin PLUS)?
Guaifenesin (Levolin PLUS) is contraindicated in patients with a known hypersensitivity to methadone hydrochloride or any other ingredient in DOLOPHINE.
Guaifenesin (Levolin PLUS) is contraindicated in any situation where opioids are contraindicated such as: patients with respiratory depression (in the absence of resuscitative equipment or in unmonitored settings), and in patients with acute bronchial asthma or hypercarbia.
Guaifenesin (Levolin PLUS) is contraindicated in any patient who has or is suspected of having a paralytic ileus.
Levosalbutamol (Levolin PLUS) indications
The prevention and relief of bronchospasm in all forms of bronchial asthma. Reversible airway obstruction in chronic bronchitis and emphysema, bronchial obstruction in children.
Threatening preterm labor with uterine contractions; birth to 37-38 weeks of pregnancy; isthmic-cervical insufficiency, decrease in fetal heart rate, depending on uterine contractions during opening of the cervix and expulsion. As a preventive measure during surgery on the pregnant uterus (the imposition of a circular suture with the lack of internal os of the uterus).
Uses of Levosalbutamol (Levolin PLUS) in details
To treat and prevent bronchospasm (constriction of airways causing breathing difficulties) in reversible obstructive airway disease like asthma, or some cases of chronic bronchitis.
Levosalbutamol (Levolin PLUS) dosage
Levosalbutamol (Levolin PLUS) for oral use as a means of extending the broncho adults and children over 12 years - 2.4 mg 3-4 times / day; if necessary, the dose may be increased to 8 mg 4 times / day. Children aged 6-12 years - 2 mg 3-4 times / day; children 2-6 years - 1-2 mg 3 times / day.
Levosalbutamol (Levolin PLUS) for inhalation use dose depends on the applied dosage form, frequency of use depends on the testimony and the clinical situation.
As a tocolytic agent used as IV infusion in dose of 1-2 mg.
Levosalbutamol (Levolin PLUS) interactions
Diuretics, corticosteroids and xanthines may augment hypokalaemia. CV effects potentiated by MAOIs, TCAs, sympathomimetics. Increases absorption of sulfamethoxazole when used together. May markedly increase heart rate and BP when used with atomoxetine. Reduces serum levels of digoxin. Hypokalaemia induced by salbutamol increases the risk of digitalis toxicity. BP should be closely monitored if linezolid is used concurrently with salbutamol.
Levosalbutamol (Levolin PLUS) side effects
Cardiovascular system: a transient expansion of peripheral blood vessels, a moderate tachycardia.
Central nervous system: headache, dizziness, nausea, vomiting.
Metabolic: hypokalaemia.
Allergic reactions: in a few cases - angioedema, allergic reactions in the form of skin rashes, urticaria, hypotension, collapse.
Other: Tremor of hands, inner trembling, tension, rarely - paradoxical bronchoconstriction, muscle cramps.
Levosalbutamol (Levolin PLUS) contraindications
The threat of miscarriage in I and II trimesters of pregnancy, premature placental abruption, bleeding or toxemia in the III trimester of pregnancy, infancy to 2 years; hypersensitivity to salbutamol.
Смотрите также:
Каковы возможные побочные эффекты Амброксола (Levolin PLUS)?
Относится к альбутеролу: пероральный сироп, пероральная таблетка, пероральный препарат с расширенным высвобождением
Другие лекарственные формы:
- ингаляционный аэрозольный порошок, ингаляционная капсула, ингаляционный порошок, ингаляционный раствор
Помимо необходимых эффектов, альбутерол (активный ингредиент, содержащийся в амброксоле (Levolin PLUS)) может вызывать нежелательные побочные эффекты, требующие медицинской помощи.
Основные побочные эффекты
Если при приеме альбутерола возникает какой-либо из следующих побочных эффектов, немедленно обратитесь к врачу:
Более распространенный:
- Шакство в ногах, руках, руках или ногах
- дрожание или тряска рук или ног
- Быстрое, нерегулярное, стучащее или учащенное сердцебиение или пульс
- Кашель
- затрудненное дыхание
- трудности с глотанием
- крапивница или рубцы
- хрипота
- большой, похожий на улей отек на лице, веках, губах, языке, горле, руках, ногах, ступнях или половых органах
- шумное дыхание
- покраснение кожи
- одышка
- кожная сыпь
- медленное или нерегулярное дыхание
- отек рта или горла
- стеснение в груди
- хрипит
- Агитация
- тревога
- боль в руке, спине или челюсти
- помутнение зрения
- боль в груди или дискомфорт
- путаница
- судороги
- дополнительные сердцебиения
- обморок
- галлюцинации
- Головная боль
- раздражительность
- легкомысленность
- настроение или психические изменения
- мышечные боли или судороги
- мышечный спазм или рывок всех конечностей
- нервозность
- кошмары
- стучать в уши
- беспокойство
- внезапная потеря сознания
- потливость
- полное рывок тела
- необычное чувство волнения
- рвота
Незначительные побочные эффекты
Некоторые побочные эффекты альбутерола могут не нуждаться в медицинской помощи. Когда ваше тело привыкает к лекарству, эти побочные эффекты могут исчезнуть. Ваш медицинский работник может помочь вам предотвратить или уменьшить эти побочные эффекты, но проверьте их, продолжаются ли какие-либо из следующих побочных эффектов или вас это беспокоит:
Менее распространенный:
- Головокружение
- чувство тепла
- раздражительность
- тошнота
- покраснение лица, шеи, рук, а иногда и верхней части груди
- бессонница
- проблемы с удержанием или выделением мочи
- проблемы со сном
- не в состоянии спать
- Сонливость
- необычная сонливость
- Плохой, необычный или неприятный (после) вкус
- изменение вкуса
- чувство постоянного движения себя или окружения
- завязывание рта
- грубый, колючий звук в голос
- ощущение вращения
- стеснение в горле
Каждая ретард-капсула содержит гидрохлорид амброксола (леволина ПЛЮС) 75 мг.
Каждая таблетка содержит гидрохлорид амброксола (леволина ПЛЮС) 30 мг.
Каждый 5 мл сиропа содержит амброксол (леволин ПЛЮС) гидрохлорид 15 или 30 мг.
Каждый мл сиропа (капли для младенцев) содержит 6 мг гидрохлорида амброксола (леволина ПЛЮС).
Гидрохлорид амброксола (леволина ПЛЮС) представляет собой гидрохлорид транс-4 - [(2-амино-3,5-дибромбензил) амино] циклогексанола.
Он также содержит следующие вспомогательные вещества: Капсулы для сала: Кросповидон коллидон CL, карнаубский воск, стеариловый спирт, стеарат магния.
Таблетки: Лактоза, кукурузный крахмал, коллоидный кремнезем, стеарат магния.
Сироп: Очищенная вода, сорбитоловая жидкость, глицерин 85%, аромат древесной ягоды (только 15 мг), аромат клубники (только 30 мг), гидроксиэтилцеллюлоза, бензойная кислота, ацесульфам калия, аромат ванили.
Младенческие капли: Гидроксиэтилцеллюлоза, раствор сорбита, глицерин 85%, сахарин натрия, ароматизаторы фармы, ментол, бензойная кислота, пропиленгликоль.
Синтетический опиоид, который используется в качестве гидрохлорида. Это опиоидный анальгетик, который в основном является муопиоидным агонистом. Он имеет действия и использует, подобные морфию. Он также оказывает депрессивное действие на центр кашля и может быть назначен для контроля при неизлечимом кашле, связанном с неизлечимым раком легкого. Гуаифенесин (Levolin PLUS) также используется в качестве части лечения зависимости от опиоидных препаратов, хотя длительное использование самого метадона может привести к зависимости. (От Мартиндейла, Экстра Фармакопея, 30-е изд, стр. 1082-3)